The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Immunology Drug Market Research Report 2024
Synopsis
The immune system is an assembly of structures and processes inside the body to protect against possibly damaging foreign bodies and diseases. It identifies various threats like bacteria, viruses, and parasites and distinguishes them from body's healthy tissues. When the immune system weakness and lose the capability to detect and destroy the abnormal cells or body attacks and damages its tissues lead to diseases like cancer and autoimmune diseases. Immunotherapy is a process which includes the treatment by inducing, enhancing or suppressing an immune system to fight against the diseases.
The global Immunology Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Immunology Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunology Drug.
Report Scope
The Immunology Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immunology Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunology Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Active Biotech
Eli Lilly and Company
Autoimmune Inc.
Pfizer
GlaxoSmithKline plc
Seattle Genetics
Genentech
F. Hoffmann-La Roche Ltd.
Eisai Co.
Bayer AG
Sanofi Aventis LLC.
Segment by Type
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Immunosuppressive medication
Others
Segment by Application
Hospitals
Clinics
Cancer Research Centers and Institutes
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Immunology Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Immunology Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The immune system is an assembly of structures and processes inside the body to protect against possibly damaging foreign bodies and diseases. It identifies various threats like bacteria, viruses, and parasites and distinguishes them from body's healthy tissues. When the immune system weakness and lose the capability to detect and destroy the abnormal cells or body attacks and damages its tissues lead to diseases like cancer and autoimmune diseases. Immunotherapy is a process which includes the treatment by inducing, enhancing or suppressing an immune system to fight against the diseases.
The global Immunology Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Immunology Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunology Drug.
Report Scope
The Immunology Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immunology Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunology Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Active Biotech
Eli Lilly and Company
Autoimmune Inc.
Pfizer
GlaxoSmithKline plc
Seattle Genetics
Genentech
F. Hoffmann-La Roche Ltd.
Eisai Co.
Bayer AG
Sanofi Aventis LLC.
Segment by Type
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Immunosuppressive medication
Others
Segment by Application
Hospitals
Clinics
Cancer Research Centers and Institutes
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Immunology Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Immunology Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Immunology Drug Market Overview
1.1 Product Overview and Scope of Immunology Drug
1.2 Immunology Drug Segment by Type
1.2.1 Global Immunology Drug Market Value Comparison by Type (2024-2030)
1.2.2 Monoclonal Antibodies (mAb)
1.2.3 Antibody Drug Conjugates
1.2.4 Immunosuppressive medication
1.2.5 Others
1.3 Immunology Drug Segment by Application
1.3.1 Global Immunology Drug Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Centers and Institutes
1.4 Global Immunology Drug Market Size Estimates and Forecasts
1.4.1 Global Immunology Drug Revenue 2019-2030
1.4.2 Global Immunology Drug Sales 2019-2030
1.4.3 Global Immunology Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Immunology Drug Market Competition by Manufacturers
2.1 Global Immunology Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Immunology Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Immunology Drug Average Price by Manufacturers (2019-2024)
2.4 Global Immunology Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Immunology Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Immunology Drug, Product Type & Application
2.7 Immunology Drug Market Competitive Situation and Trends
2.7.1 Immunology Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Immunology Drug Players Market Share by Revenue
2.7.3 Global Immunology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Immunology Drug Retrospective Market Scenario by Region
3.1 Global Immunology Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Immunology Drug Global Immunology Drug Sales by Region: 2019-2030
3.2.1 Global Immunology Drug Sales by Region: 2019-2024
3.2.2 Global Immunology Drug Sales by Region: 2025-2030
3.3 Global Immunology Drug Global Immunology Drug Revenue by Region: 2019-2030
3.3.1 Global Immunology Drug Revenue by Region: 2019-2024
3.3.2 Global Immunology Drug Revenue by Region: 2025-2030
3.4 North America Immunology Drug Market Facts & Figures by Country
3.4.1 North America Immunology Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Immunology Drug Sales by Country (2019-2030)
3.4.3 North America Immunology Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Immunology Drug Market Facts & Figures by Country
3.5.1 Europe Immunology Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Immunology Drug Sales by Country (2019-2030)
3.5.3 Europe Immunology Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immunology Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Immunology Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Immunology Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Immunology Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Immunology Drug Market Facts & Figures by Country
3.7.1 Latin America Immunology Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Immunology Drug Sales by Country (2019-2030)
3.7.3 Latin America Immunology Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Immunology Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Immunology Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Immunology Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Immunology Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Immunology Drug Sales by Type (2019-2030)
4.1.1 Global Immunology Drug Sales by Type (2019-2024)
4.1.2 Global Immunology Drug Sales by Type (2025-2030)
4.1.3 Global Immunology Drug Sales Market Share by Type (2019-2030)
4.2 Global Immunology Drug Revenue by Type (2019-2030)
4.2.1 Global Immunology Drug Revenue by Type (2019-2024)
4.2.2 Global Immunology Drug Revenue by Type (2025-2030)
4.2.3 Global Immunology Drug Revenue Market Share by Type (2019-2030)
4.3 Global Immunology Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Immunology Drug Sales by Application (2019-2030)
5.1.1 Global Immunology Drug Sales by Application (2019-2024)
5.1.2 Global Immunology Drug Sales by Application (2025-2030)
5.1.3 Global Immunology Drug Sales Market Share by Application (2019-2030)
5.2 Global Immunology Drug Revenue by Application (2019-2030)
5.2.1 Global Immunology Drug Revenue by Application (2019-2024)
5.2.2 Global Immunology Drug Revenue by Application (2025-2030)
5.2.3 Global Immunology Drug Revenue Market Share by Application (2019-2030)
5.3 Global Immunology Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Immunology Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Laboratories Immunology Drug Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Active Biotech
6.2.1 Active Biotech Corporation Information
6.2.2 Active Biotech Description and Business Overview
6.2.3 Active Biotech Immunology Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Active Biotech Immunology Drug Product Portfolio
6.2.5 Active Biotech Recent Developments/Updates
6.3 Eli Lilly and Company
6.3.1 Eli Lilly and Company Corporation Information
6.3.2 Eli Lilly and Company Description and Business Overview
6.3.3 Eli Lilly and Company Immunology Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lilly and Company Immunology Drug Product Portfolio
6.3.5 Eli Lilly and Company Recent Developments/Updates
6.4 Autoimmune Inc.
6.4.1 Autoimmune Inc. Corporation Information
6.4.2 Autoimmune Inc. Description and Business Overview
6.4.3 Autoimmune Inc. Immunology Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Autoimmune Inc. Immunology Drug Product Portfolio
6.4.5 Autoimmune Inc. Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Immunology Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Immunology Drug Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 GlaxoSmithKline plc
6.6.1 GlaxoSmithKline plc Corporation Information
6.6.2 GlaxoSmithKline plc Description and Business Overview
6.6.3 GlaxoSmithKline plc Immunology Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GlaxoSmithKline plc Immunology Drug Product Portfolio
6.6.5 GlaxoSmithKline plc Recent Developments/Updates
6.7 Seattle Genetics
6.6.1 Seattle Genetics Corporation Information
6.6.2 Seattle Genetics Description and Business Overview
6.6.3 Seattle Genetics Immunology Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Seattle Genetics Immunology Drug Product Portfolio
6.7.5 Seattle Genetics Recent Developments/Updates
6.8 Genentech
6.8.1 Genentech Corporation Information
6.8.2 Genentech Description and Business Overview
6.8.3 Genentech Immunology Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Genentech Immunology Drug Product Portfolio
6.8.5 Genentech Recent Developments/Updates
6.9 F. Hoffmann-La Roche Ltd.
6.9.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.9.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Product Portfolio
6.9.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.10 Eisai Co.
6.10.1 Eisai Co. Corporation Information
6.10.2 Eisai Co. Description and Business Overview
6.10.3 Eisai Co. Immunology Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Eisai Co. Immunology Drug Product Portfolio
6.10.5 Eisai Co. Recent Developments/Updates
6.11 Bayer AG
6.11.1 Bayer AG Corporation Information
6.11.2 Bayer AG Immunology Drug Description and Business Overview
6.11.3 Bayer AG Immunology Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Bayer AG Immunology Drug Product Portfolio
6.11.5 Bayer AG Recent Developments/Updates
6.12 Sanofi Aventis LLC.
6.12.1 Sanofi Aventis LLC. Corporation Information
6.12.2 Sanofi Aventis LLC. Immunology Drug Description and Business Overview
6.12.3 Sanofi Aventis LLC. Immunology Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sanofi Aventis LLC. Immunology Drug Product Portfolio
6.12.5 Sanofi Aventis LLC. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immunology Drug Industry Chain Analysis
7.2 Immunology Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immunology Drug Production Mode & Process
7.4 Immunology Drug Sales and Marketing
7.4.1 Immunology Drug Sales Channels
7.4.2 Immunology Drug Distributors
7.5 Immunology Drug Customers
8 Immunology Drug Market Dynamics
8.1 Immunology Drug Industry Trends
8.2 Immunology Drug Market Drivers
8.3 Immunology Drug Market Challenges
8.4 Immunology Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
